As the global healthcare research landscape evolves at lightning speed, we need to change the way we approach healthcare data by breaking down silos, fostering knowledge sharing, and democratizing access to anonymized real-world health insights. And as the volume and complexity of healthcare data continue to grow, the integration of next-generation data analytics and artificial intelligence is reshaping germline variant analysis, offering researchers the tools to uncover actionable insights, streamline processes, and tackle some of the field's most pressing challenges.
This webcast will explore how to unlock the potential of germline research with cutting-edge advancements in AI-powered workflows, highlighting the New Generation SOPHiA DDM Platform.
Built by users, for users, this AI-powered platform unites healthcare institutions worldwide, paving the way for a future of collective intelligence in precision medicine by streamling sequencing data analysis and interpretation, simplifying variant prioritization, and accelerating reporting.
You will learn:
* The latest breakthroughs in AI applications for germline research
* Strategies for enhancing data accuracy, scalability, and speed
* Real-world examples of how AI-driven workflows are solving complex research problems
Unable to join the live event? Watch on demand. Register now to ensure that you receive information on how to gain access after the live event.
This webcast has been produced by SOPHiA GENETICS who retains sole responsibility for content. About this content.
Ariel I. Suarez, Biochemist, Department of Molecular Biology, IACA Laboratorios
Ariel Suarez, PhD, graduated in 2002 with a degree in Biochemistry from the Universidad Nacional del Sur in BahÃa Blanca, Buenos Aires. He completed his residency in Clinical Biochemistry at CEMIC University in Buenos Aires from 2003 to 2007, further enhancing his expertise with a fellowship in Molecular Techniques at the Children's Hospital of Philadelphia (CHOP) at the University of Pennsylvania in 2006. Since 2007, Dr. Suarez has been a dedicated member of the Department of Genetics and Molecular Biology, and as of 2022, he also serves on the staff of the Department of Molecular Pathology.
Amanda Verpoorte, Head of Platform Product Management, SOPHiA GENETICS
Amanda Verpoorte, PhD, brings a unique blend of expertise across fundamental research in biomedical sciences, engineering, and business management consulting. She joined SOPHiA GENETICS in October 2020 as Medical Innovation Strategy Director, from McKinsey & Company, where she served dozens of clients in the BioPharma sector, advising global pharmaceutical companies, mid-size players, and biotechs alike across the pharma value chain with a major focus on oncology and rare diseases. Amanda has been leading the global platform product management team since September 2023. Prior to that, Amanda was a post-doctoral fellow at the Swiss Federal Institute of Technology (EPFL), where she carried out her PhD in engineering and biomedical sciences.
Alison Halliday, Freelance Science Writer
Alison Halliday, PhD, is a freelance science writer, focusing on life sciences, biomedicine and health stories. Following her doctorate at the University of Newcastle and postdoctoral research into human molecular genetics at University College London, she moved into science communications. With more than 25 years of experience spanning academia, industry and non-profit sectors - including a decade at Cancer Research UK - she has collaborated with Nature Custom Media since 2019.
